Hyaluronic Acid Products Market: Three Cycle Injection Products Segment to Remain Dominant Throughout the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027
- REP-GB-486
- 2017-11-08
- Category: Healthcare, Pharmaceuticals and Medical devices
- 214 Pages
- Format:
Innovations are fuelling process and product development in the global hyaluronic acid products market
There is ample opportunity for both incumbents and new entrants in hyaluronic acid products market as there is a continuous search for more comfortable, advanced, and efficient products. Product safety and efficacy are the key concerns that need to be addressed in hyaluronic acid products market. Hyaluronic acid products have common side-effects such as skin inflammation, reddening, pain, and itching that often remain for extended periods of time. Therefore, process innovation in product formation or manufacturing of new dosage that increases patient convenience is critical in hyaluronic acid products market. Developing the product manufacturing process and making it cost-efficient with greater efficacy would naturally attract more customers to opt for hyaluronic acid treatments.
Combination products are a notable trend to tap into in the global hyaluronic acid products market
The hyaluronic acid products market is quite mature in developed regions such as Europe where patients have the awareness of such treatments and are able to afford them as well. There is a saturation of hyaluronic acid products in hyaluronic acid products market with changes in the molecular weight. A recent trend witnessed is that of combination products and the pipelines of key stakeholders in hyaluronic acid products market have a combo of corticosteroid and hyaluronic acid based injections. This game-changing concoction provides the pain relieving effect of corticosteroids with the long-lasting influence of hyaluronic acids that can sometimes last for half a year. The three-cycle injection product segment is the largest in the Western Europe hyaluronic acid products market and is expected to cross US$ 430 million by end 2027.
Next-gen injections are on the anvil in the global hyaluronic acid products market
Intra-articular hyaluronic acid or IAHA injection manufacturers are investing heavily in R&D and trying to strengthen their competitive position in the IAHA market with a combination of hyaluronic acid products. On account of its excellent physiochemical properties, it is very easy to merge hyaluronic acid products with other pharmaceuticals such as corticosteroids. For e.g. – Anika’s product CINGAL is considered a viscoelastic supplement for synovial fluid in human joints and a third-gen viscosupplementation product. However, this product is not yet approved for use by US regulatory authorities. Companies in the North America hyaluronic acid products market would be advised to focus their attention on the three cycle injection products segment as it is anticipated to grow with the highest CAGR of 8.1% from 2017 to 2027.
High costs can stifle prospects of the hyaluronic acid products market in price-sensitive emerging economies
Products in hyaluronic acid products market are highly efficient but a majority of patients are unable to afford them because of their high cost. Single-injection and three-injection cycles in particular are premium priced products making it challenging for them to appeal to customers in emerging markets with a limited disposable income. The high price is usually because of the difficulties in manufacturing hyaluronic acid. Another constraint is the numerous side-effects witnessed after undergoing hyaluronic acid treatment.
Alternative treatments inhibit unencumbered growth of the hyaluronic acid products market
Alternative treatments have become popular in recent times. In the case of osteoporosis, over-the-counter medication or even COX-2 inhibitors can be provided if the pain is unbearable. Physical therapies and steroid injection deliver temporary pain relief and decrease inflammation. Sometimes arthroscopic surgery, joint replacement, or osteotomy are recommended for osteoporosis.
Cohesive report structure that flows in a logical format
Hyaluronic acid is a glycosaminoglycan widely distributed throughout neural, epithelial, and connective tissue. The report titled ‘Hyaluronic Acid Products Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ sheds light on the different factors poised to impact growth of the hyaluronic acid products market during the course of the forecast period. The report begins with a succinct yet comprehensive executive summary for a first-glance that encapsulates the market overview, analysis, and recommendations. An introduction to the global hyaluronic acid products market that consists of the definition and taxonomy follows. An in-depth assessment of the macroeconomic factors such as regulations, opportunity analysis, revenue growth, and the global value chain is par for the course. The historical analysis of the hyaluronic acid products market for the period 2012- 2026 is compared and contrasted with the decadal forecast to present a complete picture of the present and future prospects in the hyaluronic acid products market.
The successive chapters highlight the value forecast of the hyaluronic acid products market across the studied regions. The crucial market dynamics along with an impact analysis of the drivers and restraints that influence the hyaluronic acid products market are provided herein. A forecast of the hyaluronic acid products market for the various market segments and sub-segments for the regions is mentioned. The regional sections conclude with a market attractiveness index along with their relevance and impact on the overall hyaluronic acid products market.
Hyaluronic Acid Products Market: Taxonomy
|
Product Type |
Application |
Region |
|---|---|---|
|
|
|
A crucial chapter of the hyaluronic acid products market report focuses on the competitive landscape. The section touches on the market structure, competition intensity map on the basis of the taxonomy, and an exhaustive competition dashboard featuring prominent companies actively involved in the hyaluronic acid products market. The leading companies have been profiled with information on their product portfolio, business strategies, recent developments, and financials. Another section of the hyaluronic acid products market report delivers a revenue forecast for market segments within specific regions. The informative report ends with a brief dive into the research methodology adopted to arrive at accurate estimations of the hyaluronic acid products market with an index of assumptions and acronyms used throughout the report.
Flowchart of the research methodology
Future Market Insights has devised a robust research methodology that can be considered an industry benchmark. The research methodology is highly systematic, multi-pronged in its approach, and includes both primary as well as secondary research to determine leading products, players, market size, applications, distributors, industry connotations, and others. The data extracted from primary and secondary research undergoes several layers of validation and cross-verification. The team of experts have many years of experience in diverse domains and their recommendations can be very useful indeed. The primary and secondary data is combined with analyst opinions’ via a triangulation method to deliver an unbiased report on the hyaluronic acid products market. To ensure fool-proof accuracy, information is only gathered from authoritative sources such as industry publications, government websites, trade journals, company statements, and press releases. Lastly, the data is thoroughly scrutinized with the help of advanced company tools to glean all the qualitative and quantitative insights of the hyaluronic acid products market.
Hyaluronic Acid Products Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Hyaluronic Acid Products Market Overview
3. Hyaluronic Acid Products Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Reimbursement Guide for Hyaluronic Acid Products
3.4. Key Regulations
4. North America Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
4.5.1. Single Cycle Injection Products
4.5.2. Three Cycle Injection Products
4.5.3. Five Cycle Injection Products
4.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
4.6.1. Single Cycle Injection Products
4.6.2. Three Cycle Injection Products
4.6.3. Five Cycle Injection Products
4.7. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
4.7.1. Osteoarthritis
4.7.2. Ophthalmic
4.7.3. Dermal Fillers
4.7.4. Vesicoureteral Reflux
4.8. Market Size (US$ Mn) Forecast By Application, 2017-2027
4.8.1. Osteoarthritis
4.8.2. Ophthalmic
4.8.3. Dermal Fillers
4.8.4. Vesicoureteral Reflux
4.9. Drivers and Restraints: Impact Analysis
4.10.Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Product Type
4.10.3. By Application
4.11. Key Representative Market Participants
4.12. Key Participants Market Presence (Intensity Map)
5. Latin America Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Regional Market Dynamics
5.5.1. Drivers
5.5.2. Restraints
5.5.3. Trends
5.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
5.6.1. Single Cycle Injection Products
5.6.2. Three Cycle Injection Products
5.6.3. Five Cycle Injection Products
5.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
5.7.1. Single Cycle Injection Products
5.7.2. Three Cycle Injection Products
5.7.3. Five Cycle Injection Products
5.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
5.8.1. Osteoarthritis
5.8.2. Ophthalmic
5.8.3. Dermal Fillers
5.8.4. Vesicoureteral Reflux
5.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
5.9.1. Osteoarthritis
5.9.2. Ophthalmic
5.9.3. Dermal Fillers
5.9.4. Vesicoureteral Reflux
5.10. Drivers and Restraints: Impact Analysis
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Product Type
5.11.3. By Application
5.12. Key Representative Market Participants Key Participants Market Presence (Intensity Map)
6. Western Europe Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012-2016
6.3.1. Germany
6.3.2. United Kingdom
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Nordics
6.3.7. Rest of Western Europe
6.4. Market Size (US$ Mn) and Volume Forecast By Country, 2017-2027
6.4.1. Germany
6.4.2. United Kingdom
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Nordics
6.4.7. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
6.5.1. Single Cycle Injection Products
6.5.2. Three Cycle Injection Products
6.5.3. Five Cycle Injection Products
6.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
6.6.1. Single Cycle Injection Products
6.6.2. Three Cycle Injection Products
6.6.3. Five Cycle Injection Products
6.7. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
6.7.1. Osteoarthritis
6.7.2. Ophthalmic
6.7.3. Dermal Fillers
6.7.4. Vesicoureteral Reflux
6.8. Market Size (US$ Mn) Forecast By Application, 2017-2027
6.8.1. Osteoarthritis
6.8.2. Ophthalmic
6.8.3. Dermal Fillers
6.8.4. Vesicoureteral Reflux
6.9. Drivers and Restraints: Impact Analysis
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By Application
6.11. Key Representative Market Participants
6.12. Key Participants Market Presence (Intensity Map)
7. Eastern Europe Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Regional Market Dynamics
7.5.1. Drivers
7.5.2. Restraints
7.5.3. Trends
7.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
7.6.1. Single Cycle Injection Products
7.6.2. Three Cycle Injection Products
7.6.3. Five Cycle Injection Products
7.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
7.7.1. Single Cycle Injection Products
7.7.2. Three Cycle Injection Products
7.7.3. Five Cycle Injection Products
7.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
7.8.1. Osteoarthritis
7.8.2. Ophthalmic
7.8.3. Dermal Fillers
7.8.4. Vesicoureteral Reflux
7.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
7.9.1. Osteoarthritis
7.9.2. Ophthalmic
7.9.3. Dermal Fillers
7.9.4. Vesicoureteral Reflux
7.10. Drivers and Restraints: Impact Analysis
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product Type
7.11.3. By Application
7.12. Key Representative Market Participants
7.13. Key Participants Market Presence (Intensity Map)
8. Japan Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
8.4.1. Single Cycle Injection Products
8.4.2. Three Cycle Injection Products
8.4.3. Five Cycle Injection Products
8.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
8.5.1. Single Cycle Injection Products
8.5.2. Three Cycle Injection Products
8.5.3. Five Cycle Injection Products
8.6. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
8.6.1. Osteoarthritis
8.6.2. Ophthalmic
8.6.3. Dermal Fillers
8.6.4. Vesicoureteral Reflux
8.7. Market Size (US$ Mn) Forecast By Application, 2017-2027
8.7.1. Osteoarthritis
8.7.2. Ophthalmic
8.7.3. Dermal Fillers
8.7.4. Vesicoureteral Reflux
8.8. Drivers and Restraints: Impact Analysis
8.9. Market Attractiveness Analysis
8.9.1. By Product Type
8.9.2. By Application
8.10. Key Representative Market Participants
8.11. Key Participants Market Presence (Intensity Map)
9. Asia Pacific Excluding Japan Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand
9.3.4. ASEAN
9.3.5. Rest of APEJ
9.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
9.4.1. China
9.4.2. India
9.4.3. Australia and New Zealand
9.4.4. ASEAN
9.4.5. Rest of APEJ
9.5. Regional Market Dynamics
9.5.1. Drivers
9.5.2. Restraints
9.5.3. Trends
9.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
9.6.1. Single Cycle Injection Products
9.6.2. Three Cycle Injection Products
9.6.3. Five Cycle Injection Products
9.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
9.7.1. Single Cycle Injection Products
9.7.2. Three Cycle Injection Products
9.7.3. Five Cycle Injection Products
9.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
9.8.1. Osteoarthritis
9.8.2. Ophthalmic
9.8.3. Dermal Fillers
9.8.4. Vesicoureteral Reflux
9.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
9.9.1. Osteoarthritis
9.9.2. Ophthalmic
9.9.3. Dermal Fillers
9.9.4. Vesicoureteral Reflux
9.10. Drivers and Restraints: Impact Analysis
9.11. Market Attractiveness Analysis
9.11.1. By Country
9.11.2. By Product Type
9.11.3. By Application
9.12. Key Representative Market Participants
9.13. Key Participants Market Presence (Intensity Map)
10. Middle East and Africa Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East and Africa
10.5. Regional Market Dynamics
10.5.1. Drivers
10.5.2. Restraints
10.5.3. Trends
10.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
10.6.1. Single Cycle Injection Products
10.6.2. Three Cycle Injection Products
10.6.3. Five Cycle Injection Products
10.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
10.7.1. Single Cycle Injection Products
10.7.2. Three Cycle Injection Products
10.7.3. Five Cycle Injection Products
10.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
10.8.1. Osteoarthritis
10.8.2. Ophthalmic
10.8.3. Dermal Fillers
10.8.4. Vesicoureteral Reflux
10.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
10.9.1. Osteoarthritis
10.9.2. Ophthalmic
10.9.3. Dermal Fillers
10.9.4. Vesicoureteral Reflux
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product Type
10.11.3. By Application
10.12. Key Representative Market Participants
10.13. Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Competition Dashboard
13.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.2.1. Allergan plc
13.2.2. Anika Therapeutics Inc.
13.2.3. Shanghai Jingfeng Pharmaceutical Co., Ltd.
13.2.4. Ferring Pharmaceuticals
13.2.5. Galderma SA (Nestle Skin Health Company)
13.2.6. Sanofi
13.2.7. Salix Pharmaceuticals Ltd. (Sub. Valeant)
13.2.8. Smith & Nephew
13.2.9. Zimmer Biomet
13.2.10. Seikagaku Corporation
13.2.11. Fidia Farmaceutici s.p.a.
14. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027 By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Japan
14.2.6. Asia Pacific Excluding Japan
14.2.7. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Japan
14.3.6. Asia Pacific Excluding Japan
14.3.7. Middle East and Africa
14.4. Market Attractiveness Analysis By Region
15. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type
15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
15.2.1. Single Cycle Injection Products
15.2.2. Three Cycle Injection Products
15.2.3. Five Cycle Injection Products
15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
15.3.1. Single Cycle Injection Products
15.3.2. Three Cycle Injection Products
15.3.3. Five Cycle Injection Products
15.4. Market Attractiveness Analysis By Product Type
16. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027, By Application
16.1. Introduction/Key Finding
16.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
16.2.1. Osteoarthritis
16.2.2. Ophthalmic
16.2.3. Dermal Fillers
16.2.4. Vesicoureteral Reflux
16.3. Market Size (US$ Mn) Forecast By Application, 2017-2027
16.3.1. Osteoarthritis
16.3.2. Ophthalmic
16.3.3. Dermal Fillers
16.3.4. Vesicoureteral Reflux
16.4. Market Attractiveness Analysis By Application
17. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
17.1. Market Size and Y-o-Y Growth
17.2. Absolute $ Opportunity
17.3. Value Chain
18. Assumptions and Acronyms Used
19. Research Methodology
Hyaluronic Acid Products Market Reports - List of Tables
Table 01 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 02 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 03 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 04 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 05 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 06 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 07 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 08 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 09 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 10 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 11 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 12 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 13 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, by Country
Table 14 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 15 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 16 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 17 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 18 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 19 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type Segment
Table 20 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Application Segment
Table 21 : Global Hyaluronic Acid Products Size (US$ Mn) Forecast by Region, 2012–2017
Table 22 : Global Hyaluronic Acid Products Size (US$ Mn) Forecast by Product Type, 2012–2017
Table 23 : Global Hyaluronic Acid Products Size (US$ Mn) Forecast by Application, 2012–2017
Hyaluronic Acid Products Market Reports - List of Figures
Figure 01 : North America Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 02 : North America Hyaluronic Acid Products Value Share By Application (2017)
Figure 03 : North America Hyaluronic Acid Products Value Share By Country (2017)
Figure 04 : North America Hyaluronic Acid Products Forecast 2017 and 2027
Figure 05 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 06 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 07 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 08 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 09 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 10 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 11 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 12 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 13 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 14 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 15 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 16 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 17 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 18 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 19 : North America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 20 : North America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 21 : North America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 22 : North America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 23 : North America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country
Figure 24 : Latin America Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 25 : Latin America Hyaluronic Acid Products Value Share By Application (2017)
Figure 26 : Latin America Hyaluronic Acid Products Value Share By Country (2017)
Figure 27 : Latin America Hyaluronic Acid Products Forecast 2017 and 2027
Figure 28 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 29 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 30 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 31 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 32 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 33 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 34 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 35 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 36 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 37 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 38 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 39 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 40 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 41 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 42 : Latin America Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 43 : Latin America Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 44 : Latin America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 45 : Latin America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 46 : Latin America Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country
Figure 47 : Western Europe Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 48 : Western Europe Hyaluronic Acid Products Value Share By Application (2017)
Figure 49 : Western Europe Hyaluronic Acid Products Value Share By Country (2017)
Figure 50 : Western Europe Hyaluronic Acid Products Forecast 2017 and 2027
Figure 51 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 52 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 53 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 54 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 55 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 56 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 57 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 58 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 59 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 60 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 61 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 62 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 63 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 64 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 65 : Western Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 66 : Western Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 67 : Western Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 68 : Western Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 69 : Western Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country
Figure 70 : Eastern Europe Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 71 : Eastern Europe Hyaluronic Acid Products Value Share By Application (2017)
Figure 72 : Eastern Europe Hyaluronic Acid Products Value Share By Country (2017)
Figure 73 : Eastern Europe Hyaluronic Acid Products Forecast 2017 and 2027
Figure 74 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 75 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 76 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 77 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 78 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 79 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 80 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 81 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 82 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 83 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 84 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 85 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 86 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 87 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 88 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 89 : Eastern Europe Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 90 : Eastern Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 91 : Eastern Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 92 : Eastern Europe Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country
Figure 93 : APEJ Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 94 : APEJ Hyaluronic Acid Products Value Share By Application (2017)
Figure 95 : APEJ Hyaluronic Acid Products Value Share By Country (2017)
Figure 96 : APEJ Hyaluronic Acid Products Forecast 2017 and 2027
Figure 97 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 98 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 99 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 100 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 101 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 102 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 103 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 104 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 105 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 106 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 107 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 108 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 109 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 110 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 111 : APEJ Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 112 : APEJ Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 113 : APEJ Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 114 : APEJ Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 115 : APEJ Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country
Figure 116 : Japan Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 117 : Japan Hyaluronic Acid Products Value Share By Application (2017)
Figure 118 : Japan Hyaluronic Acid Products Forecast 2017 and 2027
Figure 119 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 120 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 121 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 122 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 123 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 124 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 125 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 126 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 127 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 128 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 129 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 130 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 131 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 132 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 133 : Japan Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 134 : Japan Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 135 : Japan Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 136 : Japan Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 137 : MEA Hyaluronic Acid Products Value Share By Product Type (2017)
Figure 138 : MEA Hyaluronic Acid Products Value Share By Application (2017)
Figure 139 : MEA Hyaluronic Acid Products Value Share By Country (2017)
Figure 140 : MEA Hyaluronic Acid Products Forecast 2017 and 2027
Figure 141 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016
Figure 142 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 143 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Single Cycle Injection Products Segment
Figure 144 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%) (US$ Mn) Analysis, 2017–2027, by Single Cycle Injection Products Segment
Figure 145 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Three Cycle Injection Products Segment
Figure 146 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Three Cycle Injection Products Segment
Figure 147 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Five Cycle Injection Products Segment
Figure 148 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Five Cycle Injection Products Segment
Figure 149 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Osteoarthritis Segment
Figure 150 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Osteoarthritis Segment
Figure 151 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Ophthalmic Segment
Figure 152 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Ophthalmic Segment
Figure 153 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Dermal Fillers Segment
Figure 154 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Dermal Fillers Segment
Figure 155 : MEA Hyaluronic Acid Products Size (US$ Mn) Analysis, 2012–2016, by Vesicoureteral Reflux Segment
Figure 156 : MEA Hyaluronic Acid Products Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027, by Vesicoureteral Reflux Segment
Figure 157 : MEA Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Product Type
Figure 158 : MEA Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Application
Figure 159 : MEA Hyaluronic Acid Products Attractiveness Analysis, 2017–2027, by Country
Figure 160 : Global Hyaluronic Acid Products Attractiveness Analysis by Region, 2017–2027
Figure 161 : Global Hyaluronic Acid Products Attractiveness Analysis by Product Type, 2017–2027
Figure 162 : Global Hyaluronic Acid Products Attractiveness Analysis by Application, 2017–2027
Figure 163 : Global Hyaluronic Acid Products Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 164 : Global Hyaluronic Acid Products Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 165 : Global Hyaluronic Acid Products Absolute $ Opportunity (US$ Mn), 2016–2027